ArticleAlzheimer's research & therapy2026

Real-world diagnostic performance of blood-based biomarkers for Alzheimer's disease: robust performance except after stroke and high charlson comorbidity index.

Sinthujah Vigneswaran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.